OHMX.bio: state-of-the-art omics solutions OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and […] May 24, 2023 · MEDVIA
Byteflies: virtual care solutions for all Byteflies is on a mission to make virtual care available to all. The Belgian company has developed a platform for […] May 24, 2023 · MEDVIA
Unlocking the potential of patient data using healthcare data standards May 24, 2023 · Janssen Pharmaceutica
New initiative to promote transition to Organ-on-Chip technology In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by […] October 29, 2020 · BioVox
An insightful solution to eye injections Developing new therapies is sometimes not enough: for retinal indications, accurate delivery is key to making a drug work. Lowering […] November 4, 2020 · V-Bio Ventures
A life-changing discovery: CRISPR scientists awarded the 2020 Nobel Prize in Chemistry After several years of nominations, Emmanuelle Charpentier and Jennifer Doudna have finally been awarded the 2020 Nobel Prize in Chemistry […] November 4, 2020 · BioVox
DoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy Diepenbeek, Belgium – January 28, 2021 – DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for […] January 28, 2021 · Turnstone Communications
PharmaFluidics Announces Ultra-Sensitive Second Generation µPAC™ Technology for Unbiased Single Cell Proteomics Micro-chip based µPAC™ LC columns – key component in Vienna IMP study measuring the proteome at picogram level Ghent, Belgium, […] February 17, 2021 · Turnstone Communications
Proteomics PharmaFluidics Launches Next Generation µPAC™ Technology for Routine Proteomics Microfluidic chips for use in high-resolution nanoLC/MS workflows Ghent, Belgium, 27 April 2021 – PharmaFluidics NV, innovative life sciences instruments […] April 27, 2021 · Turnstone Communications
Antwerp start-up to convert CO2 into industry building blocks The University of Antwerp spin-off D-CRBN is helping carbon-emitting industries transform greenhouse gases into useful products. Using plasma technology, the […] April 28, 2021 · BioVox
Pulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. The company has announced […] May 4, 2021 · Turnstone Communications
Ground-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the […] May 18, 2021 · Turnstone Communications
Azalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with […] July 8, 2021 · Turnstone Communications
Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications. Mechelen, Belgium, August 3rd, 2021 – Spectricity, a leading provider of hyperspectral […] August 3, 2021 · Turnstone Communications
Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. […] August 18, 2021 · BioVox